Literature DB >> 32717396

Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study.

Francesca Tognon1, Stephen Sevalie2, Joseph Gassimu3, John Sesay4, Katrina Hann3, Mohamed Sheku4, Emily Bearse3, Francesco Di Gennaro5, Claudia Marotta5, Giampietro Pellizzer5, Giovanni Putoto5, Marta Lado3, Molly F Franke6, Yusupha Dibba3, Sahr Gevao4, Fenella Beynon7, Annelies W Mesman8.   

Abstract

OBJECTIVES: In Sierra Leone, very little data are available on hepatitis B virus (HBV) and hepatitis C virus (HCV) prevalence. Blood donor screening permits estimation of the prevalence of transfusion transmissible infections in a general open population. We analyzed blood donor data in Sierra Leone to estimate national viral hepatitis prevalence and identify risk factors for hepatitis infection among the donor population.
METHODS: We conducted a retrospective data analysis in five government hospitals. We collected HBV and HCV screening results, donor demographics, and donation type (family replacement or voluntary donor; first-time or repeat). Univariate and multivariate analyses were performed to determine associations between infections and socio-demographic factors.
RESULTS: The number of donors screened was 29,713. The overall prevalence was: 10.8% (3200) for HBV and 1.2% (357) for HCV. HBV infection was most strongly associated with male sex (p: <0.0001) and younger age (p: <0.0004 for the 22-27 age group). Both HBV and HCV infection were higher in certain locations.
CONCLUSION: Our findings stress the presence of viral hepatitis infection throughout the country and the need to invest in safe blood services, vaccination and treatment of viral hepatitis at the national level.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Blood donors; Epidemiology; Seroprevalence; Sierra Leone; Viral hepatitis

Year:  2020        PMID: 32717396     DOI: 10.1016/j.ijid.2020.07.030

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

Review 1.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

2.  Updated Seroprevalence of Hepatitis B Surface Antigen and Anti-Hepatitis Core Antibody Among Blood Donors in Yemen.

Authors:  Tawfique K A Alzubiery; Talal Alhazari; Jerold C Alcantara; Saleh A Majed; Abdulrahman S Bazaid; Abdu Aldarhami
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

3.  Factors Associated with HBsAg Seropositivity among Pregnant Women Receiving Antenatal Care at 10 Community Health Centers in Freetown, Sierra Leone: A Cross-Sectional Study.

Authors:  Manal Ghazzawi; Peter B James; Samuel P Massaquoi; Sahr A Yendewa; Robert A Salata; George A Yendewa
Journal:  Pathogens       Date:  2022-02-12

4.  Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone.

Authors:  George A Yendewa; Sulaiman Lakoh; Darlinda F Jiba; Sahr A Yendewa; Umu Barrie; Gibrilla F Deen; Mohamed Samai; Jeffrey M Jacobson; Foday Sahr; Robert A Salata
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

5.  Occult hepatitis B virus infections and risk factors among school-going adolescent voluntary blood donors in Kwale County Kenya, January 2020-June 2021: Cross sectional study.

Authors:  Peter Kitemi Wahome; Polly Kiende; Rocky Jumapili Nakazea; Narcis Mwakidedela Mwasowa; Gibson Waweru Nyamu
Journal:  PLoS One       Date:  2022-07-25       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.